From 9-12 february 2018, VSL#3 took part to the 2018 CDDW™ with Ferring.
The Canadian Digestive Diseases Week™ (CDDW™) is Canada's premiere educational conference which showcases the best of Canadian gastroenterology and hepatology research.
The event has been provided by The Canadia
VSL#3 will be present with Ferring at the next ECCO (European Crohn’s and Colitis Organization) Congress that will be held this year in the city of Vienna from February 14–17)
The theme for the 13th ECCO Congress 2018 is “Science improving patients’ lives,” devoting special attention to
The probiotic compound VSL#3 has an extensive impact on mucosal, peripheral, and systemic innate as well as adaptive immunity, exerting beneficial anti-inflammatory effects in intestinal as well as systemic compartments. Hence VSL#3 might be considered a therapeutic immunomodulatory tool following a
Prof. Antonio Gasbarrini is Professor at Università Cattolica del Sacro Cuore and Director of the Specialization school of Gastroenterology and Digestive Endoscopy of Policlinico Gemelli, in Rome.
Discussing on the world of Microbiota and Gut microbiota we asked him to explaine us what is a Micr
VSL#3 will take part in XVIII Convegno Nazionale ANSISA host to NH Hotel in Assago Milano.
On November 17th -18th ANSISA 's national congress (National Association of specialists in Nutritional science) will be focus on Clinical nutrition.
As part of the plenary session on Elements of integrat
Microbiota and probiotics: what's their role for organism? During the last Lunch Meeting in Rome we asked our experts to give us more details about the importance of Gut Microbiota, the contribution of probiotics in health and its market. If we consider both US and Europe, the probiotics market valu
VSL#3 with Ferring partecipated to the 25th UEG Week (United European Gastroenterology) in Barcelona where a world class faculty gathered to present newest research as well as state-of-the art clinical practice.
The 25th UEG Week Congress was concluded on November 1st and Actial Farmaceutica’s
From 10-12 September 2017 VLS#3 Pharma and Ferring will be in Rome to take part in 9th PROBIOTICS, PREBIOTICS & NEW FOODS NUTRACEUTICALS AND BOTANICALS Conference, that will be held at Università Urbaniana. 609
Scientific article "The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis" published by Journal of Histochemistry & Cytochemistry reports the analitic results of VSL#3's effects on macrophages in acute trinitrobenzene sulfo
@ Copyright 2016. VAT number Actial Farmaceutica srl IT14019081000